Publikationen, an denen er mitarbeitet Miquel Bernardo Arroyo (11)

2024

  1. Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis

    Journal of Psychiatric Research, Vol. 172, pp. 334-339

2023

  1. Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up

    International Journal of Neuropsychopharmacology, Vol. 26, Núm. 11, pp. 796-807

2022

  1. The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance

    The international journal of neuropsychopharmacology, Vol. 25, Núm. 8, pp. 666-677

2020

  1. Acute effects of a session of electroconvulsive therapy on brain-derived neurotrophic factor plasma levels

    Revista de Psiquiatria y Salud Mental

2019

  1. Effects of electroconvulsive therapy in the systemic inflammatory balance of patients with severe mental disorder

    Psychiatry and Clinical Neurosciences, Vol. 73, Núm. 10, pp. 628-635

2016

  1. BDNF and NGF Signalling in Early Phases of Psychosis: Relationship with Inflammation and Response to Antipsychotics after 1 Year

    Schizophrenia Bulletin, Vol. 42, Núm. 1, pp. 142-151

  2. Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis

    Journal of Psychiatric Research, Vol. 75, pp. 14-21

  3. Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia

    Journal of Psychiatry and Neuroscience, Vol. 41, Núm. 3, pp. E46-E55

2015

  1. Pro-/antiinflammatory dysregulation in early psychosis: Results from a 1-year follow-Up study

    International Journal of Neuropsychopharmacology, Vol. 18, Núm. 2, pp. 1-10

2014

  1. Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: Toward an integrative inflammatory hypothesis of schizophrenia

    Schizophrenia Bulletin, Vol. 40, Núm. 2, pp. 376-387

2013

  1. Peripheral endocannabinoid system dysregulation in first-episode psychosis

    Neuropsychopharmacology, Vol. 38, Núm. 13, pp. 2568-2577